RESUMEN
INTRODUCTION: The purpose of this study was to investigate the safety of performing a dipyridamole stress test and to explore the incidence of reversible perfusion defects on myocardial perfusion imaging, five to six days after primary percutaneous coronary intervention (PCI). METHODS: Forty-one patients underwent myocardial perfusion imaging using a dipyridamole stress test, five to six days after primary PCI. RESULTS: Headache, chest pain, and dizziness were the most common side effects seen after dipyridamole administration. All occurrences were mild and short lasting. ST changes on the electrocardiogram were also seen in 12% of patients. Reversible perfusion defects occurred in 17%. CONCLUSIONS: This is one of the few studies to investigate patients using a dipyridamole stress test early after primary PCI. We conclude that it is safe to perform myocardial perfusion imaging under dipyridamole administration, just a few days after primary PCI. Additionally, a high incidence (17%) of myocardial perfusion defects was seen in this group of patients. According to our investigational protocol, a second myocardial perfusion imaging examination is scheduled for six months later, in order to clarify how many of these patients suffer from restenosis, or whether the finding was merely due to early endothelial dysfunction.
Asunto(s)
Reestenosis Coronaria/diagnóstico , Dipiridamol , Ecocardiografía de Estrés , Imagen de Perfusión Miocárdica , Intervención Coronaria Percutánea/efectos adversos , Complicaciones Posoperatorias/diagnóstico , Adulto , Anciano , Dolor en el Pecho/inducido químicamente , Dipiridamol/efectos adversos , Ecocardiografía de Estrés/efectos adversos , Ecocardiografía de Estrés/métodos , Electrocardiografía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Imagen de Perfusión Miocárdica/efectos adversos , Imagen de Perfusión Miocárdica/métodos , Planificación de Atención al Paciente , Seguridad del Paciente , Cuidados Posoperatorios/efectos adversos , Cuidados Posoperatorios/métodos , Factores de Tiempo , Vasodilatadores/efectos adversosRESUMEN
Splenic-gonadal fusion is a rare congenital anomaly, in which splenic tissue is connected to the gonad. It is almost always on the left side, is difficult to be recognized, and unfortunately the final diagnosis is confirmed after an unnecessary orchiectomy in one-third of the cases. We report a case of splenic-gonadal fusion in a 6-year-old boy, referred for a palpable mass at the left testicle. Ultrasound and MRI were performed; and the final diagnosis was confirmed by Tc-99m colloid scanning. The child was operated, orchiectomy was avoided, the mass was removed, and pathology confirmed normal splenic tissue.
Asunto(s)
Bazo/anomalías , Bazo/diagnóstico por imagen , Azufre Coloidal Tecnecio Tc 99m , Testículo/anomalías , Testículo/diagnóstico por imagen , Niño , Humanos , Imagen por Resonancia Magnética , Masculino , Cintigrafía , Bazo/cirugía , Testículo/cirugía , UltrasonografíaRESUMEN
Whether internal mammary artery side branches have the potential for hemodynamically significant flow steal in cases of postcoronary surgery ischemia remains a controversial issue. We present a case in which coil embolization of two unligated side branches resulted in symptomatic improvement and resolution of ischemia as evidenced by myoview imaging.
Asunto(s)
Síndrome Coronario Agudo/etiología , Puente de Arteria Coronaria/efectos adversos , Estenosis Coronaria/cirugía , Embolización Terapéutica/métodos , Arterias Mamarias/cirugía , Síndrome Coronario Agudo/diagnóstico por imagen , Síndrome Coronario Agudo/terapia , Anciano , Angiografía Coronaria , Puente de Arteria Coronaria/métodos , Estenosis Coronaria/diagnóstico por imagen , Femenino , Humanos , Ligadura , Arterias Mamarias/diagnóstico por imagenRESUMEN
Currently, in patients with malignant melanoma there is no clear cut-off point of Breslow thickness in order to avoid unnecessary lymph node excision surgery, without missing metastatic nodes. We retrospectively studied a cohort of 64 patients, with pathologically proven malignant melanoma, who underwent lymph node scintigraphy and surgical resection of the sentinel node, during the last two years. The patients were divided into 5 groups: Group 1: Ten patients, mean age 46 ± 6 years (range 40-55 years), with Breslow thickness of the lesion 0.51-0.75 mm. Group 2: Eleven patients, mean age 41 ± 9 years (range 31-61 years), with Breslow thickness 0.76-1mm. Group 3: Twelve patients, mean age 59 ± 12 (41-76 years), with Breslow thickness 1.01-1.25 mm. Group 4: Fourteen patients, mean age 61 ± 8 (38-74 years), with Breslow thickness 1.26-1.5mm. Group 5: Seventeen patients, mean age 56 ± 10 (32-71 years), with Breslow thickness >1.5mm. We found only seven infiltrated sentinel lymph nodes. From these, 3 patients belonged to the 5th group (Breslow>1.5mm), two patients to the 4th group (Breslow 1.26-1.5mm), one patient in the 3rd group (Breslow 1.01-1.25 mm) and one patient to the 2nd group (Breslow 0.76-1mm). Since there was no positive sentinel lymph node in any patient with Breslow thickness less than < 0.75 mm, we conclude that sentinel lymph node biopsy in patients with Breslow thickness less than < 0.75 mm may not be useful and might not be carried out, except in high risk cases such as melanomas with ulceration, high mitotic rate and vertical growth phase.